| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
810 |
771 |
$160K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
823 |
796 |
$73K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
598 |
329 |
$19K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
251 |
247 |
$19K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
426 |
422 |
$13K |
| 96127 |
|
420 |
420 |
$7K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
50 |
50 |
$6K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
27 |
27 |
$4K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
129 |
127 |
$3K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
12 |
12 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
48 |
47 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
97 |
95 |
$1K |
| 99051 |
|
53 |
53 |
$1K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
53 |
53 |
$869.71 |
| 87081 |
|
66 |
65 |
$538.17 |
| 85027 |
|
38 |
38 |
$400.86 |
| 92551 |
|
34 |
34 |
$384.18 |